Howard E. Turner - 19 Oct 2023 Form 4 Insider Report for SUNLINK HEALTH SYSTEMS INC (SSY)

SEC form
4
Accepted by SEC
23 Oct 2023, 15:22:14 UTC
Prior SEC filing
16 Aug 2023
Next SEC filing
28 Nov 2023
Source filing
View source filing
Filing notes and source

Key filing fact

Howard E. Turner filed Form 4 for SUNLINK HEALTH SYSTEMS INC (SSY) on 23 Oct 2023.

Key facts

  • This page summarizes Howard E. Turner's Form 4 filing for SUNLINK HEALTH SYSTEMS INC (SSY).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 23 Oct 2023, 15:22.

Change

  • Previous filing in this sequence was filed on 16 Aug 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SSY transaction

Series C Fractional Interests

Disposed to Issuer

Transaction value
Shares
-204,785
Change %
-100%
Price
Shares after
0
Date
19 Oct 2023
Ownership
Direct
Footnotes
F1
SSY transaction

Series C Fractional Interests

Disposed to Issuer

Transaction value
Shares
-28,219
Change %
-100%
Price
Shares after
0
Date
19 Oct 2023
Ownership
SGR 401(k) Plan
Footnotes
F1
SSY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
204,785
Date
19 Oct 2023
Ownership
Direct
Footnotes
F2
SSY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
28,219
Date
19 Oct 2023
Ownership
SGR 401(k) Plan
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This Form 4 relates to the automatic redemption of all Series C Fractional Interests for no consideration following shareholder approval of the Issuer's Reincorporation Proposal at a special meeting held on October 19, 2023.

Footnote F2

This row reflects direct ownership which has not changed as a result of the transactions reported on this form.

Footnote F3

This row reflects indirect ownership which has not changed as a result of the transactions reported on this form.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .